Get the Stockscreener App
3.91
3.22%
-0.13
After Hours:
3.85
-0.06
-1.53%
Pyxis Oncology Inc stock is traded at $3.91, with a volume of 561.79K.
It is down -3.22% in the last 24 hours and up +53.33% over the past month.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
See More
Previous Close:
$4.04
Open:
$4.02
24h Volume:
561.79K
Relative Volume:
0.74
Market Cap:
$242.49M
Revenue:
-
Net Income/Loss:
$-73.79M
P/E Ratio:
-2.125
EPS:
-1.84
Net Cash Flow:
$-77.44M
1W Performance:
+9.83%
1M Performance:
+53.33%
6M Performance:
+265.42%
1Y Performance:
-0.76%
1-Day Range:
$3.72
$4.03
1-Week Range:
$3.48
$4.1691
52-Week Range:
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
Name
Pyxis Oncology Inc
Sector
Industry
Phone
(617) 221-9059
Address
321 HARRISON AVENUE, BOSTON
Compare PYXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
3.91 | 251.55M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Resumed | Stifel | Buy |
| Sep-04-25 | Initiated | Guggenheim | Buy |
| Nov-21-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-08-24 | Initiated | Stephens | Overweight |
| Aug-08-24 | Initiated | Stifel | Buy |
| May-07-24 | Resumed | Jefferies | Buy |
| Feb-09-24 | Initiated | BTIG Research | Buy |
| Jan-23-24 | Initiated | Leerink Partners | Outperform |
| Sep-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Nov-02-21 | Initiated | BofA Securities | Neutral |
| Nov-02-21 | Initiated | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Jefferies | Buy |
View All
Pyxis Oncology Inc Stock (PYXS) Latest News
Ranking Pyxis Oncology Inc. among high performing stocks via toolsJuly 2025 EndofMonth & Safe Capital Growth Tips - newser.com
Will breakout in Pyxis Oncology Inc. lead to full recoveryJuly 2025 Big Picture & Community Consensus Trade Signals - newser.com
What Fibonacci levels say about Pyxis Oncology Inc. reboundWeekly Market Summary & Safe Entry Zone Identification - newser.com
How to manage a losing position in Pyxis Oncology Inc.Weekly Stock Analysis & Community Verified Trade Signals - newser.com
Will Pyxis Oncology Inc. stock deliver better than expected guidanceEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com
Backtesting results for Pyxis Oncology Inc. trading strategiesRecession Risk & Daily Profit Maximizing Tips - newser.com
Why Pyxis Oncology Inc. stock is a value investor pick2025 Technical Patterns & Entry and Exit Point Strategies - newser.com
How Pyxis Oncology Inc. stock reacts to global recession fearsJuly 2025 PostEarnings & Reliable Price Breakout Alerts - newser.com
What makes Pyxis Oncology Inc. stock attractive to growth fundsDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com
Can Pyxis Oncology Inc. stock withstand economic slowdownEarnings Growth Summary & Risk Managed Trade Strategies - fcp.pa.gov.br
Is Pyxis Oncology Inc. stock a bargain at current levelsMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Can trapped investors hope for a rebound in Pyxis Oncology Inc.Earnings Risk Report & Community Verified Swing Trade Signals - newser.com
Custom watchlist performance reports with Pyxis Oncology Inc.Portfolio Risk Summary & Daily Entry Point Alerts - newser.com
Why Pyxis Oncology Inc. stock could see breakout soonTrade Entry Report & Smart Investment Allocation Insights - fcp.pa.gov.br
Tick level data insight on Pyxis Oncology Inc. volatilityNew Guidance & Free Technical Pattern Based Buy Signals - newser.com
Using flow based indicators on Pyxis Oncology Inc.July 2025 Chart Watch & Advanced Swing Trade Entry Alerts - newser.com
Will Pyxis Oncology Inc. stock continue upward momentumRisk Management & Precise Entry and Exit Recommendations - newser.com
Signal strength of Pyxis Oncology Inc. stock in tech scannersMarket Risk Analysis & AI Driven Price Predictions - newser.com
Pyxis Oncology (PYXS) Projected to Post Earnings on Tuesday - MarketBeat
Why Pyxis Oncology Inc. stock remains undervaluedJuly 2025 Final Week & Daily Profit Focused Stock Screening - newser.com
Will Pyxis Oncology Inc. stock benefit from AI adoptionQuarterly Trade Review & Free Daily Entry Point Trade Alerts - newser.com
Is Pyxis Oncology Inc. stock cheap at current valuationQuarterly Profit Summary & High Win Rate Trade Tips - newser.com
Will Pyxis Oncology Inc. stock split again soon2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Can Pyxis Oncology Inc. stock beat analyst upgradesBuy Signal & Accurate Buy Signal Notifications - newser.com
What analyst consensus says on Pyxis Oncology Inc. stockMarket Growth Report & Safe Swing Trade Setups - newser.com
Guggenheim Maintains Pyxis Oncology (PYXS) Buy Recommendation - Nasdaq
Guggenheim raises Pyxis Oncology stock price target to $7 on expanded trial data By Investing.com - Investing.com South Africa
Guggenheim raises Pyxis Oncology stock price target to $7 on expanded trial data - Investing.com Australia
Pyxis Oncology (NASDAQ:PYXS) Coverage Initiated by Analysts at Stifel Nicolaus - MarketBeat
Pyxis Oncology (NASDAQ:PYXS) Issues Quarterly Earnings Results - MarketBeat
Pyxis Oncology And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Is Pyxis Oncology Inc. stock bottoming outWall Street Watch & Daily Profit Focused Screening - newser.com
Pyxis Oncology Inc Stock (PYXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):